You are here

chronic cough

Nocion, chasing GSK, pulls in $62M for chronic cough drug

BioPharma Dive

Mon, 03/4/24 - 11:44 pm

Merck’s Chronic Cough Drug Fails to Secure FDA Approval for Second Time

BioSpace

Thu, 12/21/23 - 11:36 am

After watching Merck's chronic cough drama, GSK knew exactly what not to do with Bellus asset

Fierce Biotech

Thu, 11/30/23 - 10:07 am

FDA panel flags insufficient data for Merck's chronic cough drug

Reuters

Sun, 11/19/23 - 09:32 pm

FDA skeptical of Merck’s gefapixant, even after cough recount

Fierce Biotech

Thu, 11/16/23 - 11:34 am

Aldeyra's roller coaster month ends with 'positive' phase 2 chronic cough readout

Fierce Biotech

Tue, 06/27/23 - 11:33 am

Aldeyra Therapeutics

clinical trials

GSK coughs up $2B for Bellus Health

Medical Marketing and Media

Tue, 04/18/23 - 10:24 am

Merck plans to count coughs and months until gefapixant is back in FDA hands

Fierce Biotech

Fri, 08/5/22 - 10:54 am

Merck: FDA Rejects Gefapixant Application, Requests More Data

Marketwatch

Mon, 01/24/22 - 10:22 am

Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis

Endpoints

Mon, 12/13/21 - 11:06 am

Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a flop in chronic cough

Fierce Biotech

Tue, 09/28/21 - 11:38 pm

ViiV Healthcare

clinical trials

Bellus says its Merck cough rival passed a PhIIb test after earlier flop, but investors can't make up their minds

Endpoints

Mon, 09/13/21 - 10:40 am

clinical trials

FDA says it needs a little more time to decide on Merck's P2X3 for chronic cough

Endpoints

Thu, 08/12/21 - 11:12 am

Chasing Merck & Co, Bayer builds case for cough drug eliapixant

Pharmaforum

Wed, 08/4/21 - 10:49 am

clinical trials

Merck's gefapixant successful in late-stage chronic cough studies

Seeking Alpha

Tue, 09/8/20 - 11:00 am

clinical trials

Bellus hit with a setback as its PhII chronic cough drug flops on all 4 doses -- shares cremated on Wall Street

Endpoints

Mon, 07/6/20 - 10:24 am

clinical trials

Merck hits goal in cough phase 3 but yet to quash tolerability concern

Fierce Biotech

Tue, 03/17/20 - 12:14 pm

clinical trials

Bellus hopes to fuel up on IPO cash as it squares off with giant Merck on a rival drug

Endpoints

Tue, 09/3/19 - 11:30 pm

NeRRe hopes to advance cough candidate despite Phase II miss

BioCentury

Fri, 06/7/19 - 09:57 pm

clinical trials

Evotec Receives Milestone Payment for Initiating Ph II Trials of Persistent Cough Drug

CP Wire

Thu, 02/28/19 - 11:09 am